NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Neuroprotective Agents: Eighth International Neuroprotection Society Meeting Volume 1122 published December 2007
Ann. N.Y. Acad. Sci. 1122: 50–68 (2007). doi: 10.1196/annals.1403.004
Copyright © 2007 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by VIRMANI, A.
Articles by GAETANI, F.
Search for Related Content
PubMed
PubMed Citation
Articles by VIRMANI, A.
Articles by GAETANI, F.

Part I. Pathophysiology of Nervous System Insults

Metabolic Syndrome in Drug Abuse

ASHRAF VIRMANIa, ZBIGNIEW K. BINIENDAb, SYED F. ALIc AND FRANCO GAETANIa

a Research and Development, Sigma tau-HealthScience, Pomezia, Italy b Neurophysiology Laboratory and c Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas, USA

Key Words: nutrition • drug abuse • metabolic syndrome • L-carnitine • acetyl-L-carnitine • creatine • selenium • lipoic acid • resveratrol • cocaine • ecstasy • methamphetamine • polyunsaturated fatty acids • alcohol • brain • liver • metabolic compromise • metabolic modifier • hyperinsulinemia • hypertension • dyslipidemia • abdominal obesity • free radicals • reactive oxygen species • vitamins • zinc • thiamine • supplements • diabetes • amphetamines

Address for correspondence: Ashraf Virmani, Ph.D., Sigma tau-HealthScience, Via Treviso 4, Pomezia 00040, Italy. Voice: +(39)-06-916-19721; fax: +(39)-06-916-12631. ashraf.virmani{at}st-hs.it

Drug abuse is associated with significant health risk. Whether drug abusers are at a higher risk of suffering the metabolic syndrome is not widely known. The metabolic syndrome is a cluster of metabolic abnormalities, including hyperinsulinemia, hypertension, dyslipidemia, and abdominal obesity, and is probably triggered by initial imbalances at the cellular level in various critical metabolic pathways. These initially small metabolic imbalances are believed to cascade with time and lead to larger problems. Some indications that drug abuse may increase the risk of the metabolic syndrome include the following:

  • • Drug-abusing patients have higher rates of diabetes complications.
  • • Substance abuse is a significant contributing factor for treatment noncompliance in diabetes.
  • • Nutrition education can enhance substance abuse treatment outcomes.

Each type of drug/substance abuse has a unique profile of toxicity. For example, the amphetamines generally affect the cardiovascular and neurological systems, worsening the risk factors for the metabolic syndrome. Methamphetamine (meth) abusers suffer cognitive deficits and abnormal metabolic activity, which affect nutritional status. This condition is further worsened by a drastic reduction in oral health in meth abusers, resulting in improper chewing and, therefore, digestion. Nutritional deficiency in combination with drug abuse would increase the risk of developing the metabolic syndrome by increasing cell damage, augmenting excitotoxicity, reducing energy production, and lowering the antioxidant potential of the cells. Another potential risk factor in the development of the metabolic syndrome is genetic vulnerability, especially in combination with drug abuse and nutritional deficiencies. The strategies available to treat this problem include pharmacological agents as well as dietary antioxidants. Such measures may be useful in reducing drug abuse–related toxicity that may lead to the metabolic syndrome.






footerLeft footerRight